期刊文献+

山广志教授治疗前列腺癌骨转移的临证经验 被引量:9

Shan Guangzhi's Experience for the Treatment of Bone Metastasis of Prostate Cancer
下载PDF
导出
摘要 [目的]总结山广志教授临床治疗前列腺癌骨转移的经验。[方法]通过跟随山广志教授临诊实践以及深入学习山教授的医案,总结山教授治疗前列腺癌骨转移的临证经验,并归纳整理山教授治疗该病的学术思想。[结果]山教授认为肾虚是前列腺癌骨转移的基本病机,同时伴有脾胃亏虚以及机体气机逆乱。前列腺癌骨转移患者最常出现的症状就是癌性骨痛,其原因不外乎"不通则痛"和"不荣则痛"。在治疗时应从内外两方面入手,内治法以滋补肾气填精固本为根本,同时注重调理脾胃,疏通机体气机;外治法以"通络活血"为治则,能有效减轻患者的疼痛,再配合以食疗,从而从整体上提高患者的生存质量。[结论]山教授在治疗前列腺癌骨转移方面的经验,疗效确切,值得学习和推广。 [Objective] To sum up professor Shan Guangzhi's clinical experience for the treatment of bone metastasis of prostate cancer. [Method] From following professor Shan Guangzhi in the clinical practice and further studying his medical cases, summarizes his experience in the treatment of prostate cancer bone metastases,and sums up his academic thoughts for the treatment of the disease.[Result] Professor Shan Guangzhi thinks that deficiency of the kidney is the basic pathogenesis of bone metastases of prostate cancer,at the same time accompanied by spleen deficiency and qi-movement disturbance. To prostate cancer patients with bone metastases, pain is the most common symptom,the reason for it is that "stagnation leading to pain" and "poor nutrition lead to pain". The treatment should focus on two aspects,both the inner treatment and the external treatment; the internal treatment regards invigorating Qi and tonifying the kidney as the basis,also pays attention to regulate spleen and stomach,dredges the body down;the external treatment regards "promoting blood circulation to remove meridian obstruction" as the rule,it can effectively relieve patients" pain,and cooperates with diet,as a whole to improve the quality of survival in patients. [Conclusion]Professor Shah Guangzhi's experience in the treatment of bone metastasis of prostate cancer has exact curative effect, worth learning and promotion.
出处 《浙江中医药大学学报》 CAS 2016年第2期131-133,共3页 Journal of Zhejiang Chinese Medical University
关键词 前列腺癌 骨转移 肾气 脾胃 气机 食疗 prostate cancer bone metastasis kidney Qi spleen and stomach Qi function diet Therapy
  • 相关文献

参考文献8

二级参考文献39

  • 1赵翌,李颖,白松,高亚杰,刘基巍.唑来膦酸治疗癌症骨转移疼痛临床观察[J].癌症进展,2005,3(4):395-398. 被引量:13
  • 2郑荣生,秦凤展,陈振东,熊福星.唑来膦酸注射液治疗恶性肿瘤骨转移疼痛50例[J].中国新药杂志,2005,14(2):214-216. 被引量:5
  • 3孙辉,周均田,张燕军,陈振东,王秀问,刘基巍.注射用唑来膦酸治疗恶性肿瘤引起的溶骨性骨转移疼痛临床研究报告[J].中国肿瘤临床,2005,32(15):885-888. 被引量:15
  • 4Coloman R. Clinical aspects of metastasis bone disease. In:Coloman R, Rubens RD, eds , metastasis bone disease[J]. Camforth : The Parthenon Publishing Group Lid, 1992:11.
  • 5Major P,Lortholary A,Hon J,et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy:a pooled analysis of two randomized ,controlled clinical trials[J]. J Clin Oncol, 2001, 19:558-567.
  • 6Eydokiou A, Labrinidis A. Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis[J]. Bone, 2003,33 (2) : 216-228.
  • 7Neville-Webbe H, Coleman RE. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia[J]. Palliat Med, 2003,17(6):539-553.
  • 8Jemal A, Tiwari RC, Murray T, et al. American cancer society: cancer statistics 2004. CA Cancer J Clin, 2004, 54 : 8-29.
  • 9Stephenson RA, Smart CR, Mineau GP, et al. The fall in inci- dence of prostate cancer: on the down side of a PSA induced peak in incidence. Cancer, 1996, 77: 1342-1348.
  • 10Tarone RE, Chu KC, Brawley OW, et al. Implications of stage- specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology, 2000, 11 : 167-170.

共引文献57

同被引文献248

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部